Exanthematous Drug Eruption as a Side Effect of Teneligliptin.
作者信息
Sunil Krupa A, Francis Anju K, Finny Philip, Ike Nancy
机构信息
Intern, Nazareth College of Pharmacy, Believers Church Medical College Hospital, Thiruvalla, Kerala, India.
Department of Endocrinology and Metabolism, Believers Church Medical College Hospital, Thiruvalla, Kerala, India.
出版信息
Indian J Endocrinol Metab. 2021 Sep-Oct;25(5):470-471. doi: 10.4103/ijem.ijem_326_21. Epub 2022 Jan 12.
Abstract
摘要
相似文献
1
Exanthematous Drug Eruption as a Side Effect of Teneligliptin.作为替格列汀副作用的药疹
Indian J Endocrinol Metab. 2021 Sep-Oct;25(5):470-471. doi: 10.4103/ijem.ijem_326_21. Epub 2022 Jan 12.
2
Dermoscopy as an auxiliary tool in the early differential diagnosis of acute generalized exanthematous pustulosis (AGEP) and exanthematous (morbilliform) drug eruption.皮肤镜作为急性泛发性脓疱性皮病（AGEP）和疹性（麻疹样）药疹早期鉴别诊断的辅助工具。
J Am Acad Dermatol. 2016 Feb;74(2):e29-31. doi: 10.1016/j.jaad.2015.10.030.
3
[Drugs associated with acute generalized exanthematic pustulosis].[与急性泛发性脓疱性皮病相关的药物]
Ann Dermatol Venereol. 2003 Jun-Jul;130(6-7):612-8.
4
A high incidence of exanthematous eruption associated with niacin/laropiprant combination in Hong Kong Chinese patients.在香港的华裔患者中，烟酸/洛哌丁胺联合用药会出现高发生率的出疹性皮疹。
J Clin Pharm Ther. 2013 Dec;38(6):528-32. doi: 10.1111/jcpt.12096. Epub 2013 Sep 10.
5
[Acute generalized exanthematous pustulosis due to fluconazole].[氟康唑所致急性泛发性脓疱性皮病]
Ann Dermatol Venereol. 2002 Mar;129(3):294-7.
6
Diffuse exanthematous drug eruption associated with intravenous immunoglobulin.与静脉注射免疫球蛋白相关的弥漫性疹性药物疹
Proc (Bayl Univ Med Cent). 2020 Aug 19;34(1):81-82. doi: 10.1080/08998280.2020.1805672.
7
Acute generalized exanthematous pustulosis: an unusual side effect of meropenem.急性泛发性脓疱性皮病：美罗培南一种不寻常的副作用。
Indian J Dermatol. 2010 Apr-Jun;55(2):176-7. doi: 10.4103/0019-5154.62759.
8
Human pharmacokinetic profiling of the dipeptidyl peptidase-IV inhibitor teneligliptin using physiologically based pharmacokinetic modeling.使用基于生理的药代动力学模型对二肽基肽酶-IV抑制剂替格列汀进行人体药代动力学分析。
Biopharm Drug Dispos. 2015 Apr;36(3):148-62. doi: 10.1002/bdd.1928. Epub 2015 Jan 28.
9
Acute localised exanthematous pustulosis (ALEP) induced by clindamycin in pregnancy.孕期克林霉素诱发的急性局限性脓疱性皮疹病（ALEP）
Australas J Dermatol. 2015 Aug;56(3):e55-8. doi: 10.1111/ajd.12135. Epub 2014 Jan 14.
10
Effect of ketoconazole on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor teneligliptin: an open-label study in healthy white subjects in Germany.酮康唑对二肽基肽酶-4抑制剂替格列汀药代动力学的影响：德国健康白人受试者的一项开放标签研究。
Clin Ther. 2014 May;36(5):760-9. doi: 10.1016/j.clinthera.2014.03.002. Epub 2014 Apr 13.
引用本文的文献
1
Dermatological side effects of dipeptidyl Peptidase-4 inhibitors in diabetes management: a comprehensive review.二肽基肽酶-4抑制剂在糖尿病管理中的皮肤副作用：一项综述
Clin Diabetes Endocrinol. 2024 Mar 25;10(1):6. doi: 10.1186/s40842-024-00165-w.
本文引用的文献
1
Diffuse erythematous rash after teneligliptin therapy: A case report.替格列汀治疗后出现弥漫性红斑疹：一例报告。
J Family Med Prim Care. 2018 Nov-Dec;7(6):1571-1572. doi: 10.4103/jfmpc.jfmpc_283_18.
2
Drug-induced generalized skin eruption in a diabetes mellitus patient receiving a dipeptidyl peptidase-4 inhibitor plus metformin.二肽基肽酶-4 抑制剂联合二甲双胍致糖尿病患者泛发性皮肤疹。
Diabetes Ther. 2012 Dec;3(1):14. doi: 10.1007/s13300-012-0014-7. Epub 2012 Nov 6.
3
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.
Zotero 插件